UNSPSC 51271913: Proparacaine or proxymetacaine

This classification denotes an anesthetic agent with the molecular formula C16H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B4OB0JHI1X, chemically known as benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester but generally known as proxymetacaine, which bears US NIH Compound Identifier 4935. European Medicines Agency schedules Proxymetacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10152MIG.

UNSPSC 51271913 Proparacaine or proxymetacaine is a Commodity code covering topical anesthetic eye drops supplied through cooperative purchasing vehicles to state and local government health facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon. The procurement centers on pharmaceuticals supplied through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with vendors required to provide comprehensive pricing by National Drug Code (NDC), along with detailed product information including SKUs, UPCs, generic descriptions, strength, dosage form, trade names, packaging configurations, and manufacturing locations. Vendors must hold cGMP certification, comply with the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers, and carry commercial general liability insurance of $5,000,000 per occurrence. The RFP does not identify set-aside designations for disadvantaged enterprises.

MMCAP covers Minnesota and Oregon, with activity concentrated in the upper Midwest cooperative purchasing network. The RFP issued January 20, 2026, closed for questions February 18, 2026, and requires proposals by March 26, 2026, with awarded vendors to be provided to wholesalers by May 15, 2026 and resulting agreements effective July 1, 2026. Evaluation weights pricing competitiveness at 75 percent, fixed pricing at 10 percent, compliance with administrative data format and EDI capability at 5 percent each, and agreement to a 3 percent administrative fee at 5 percent. Contract terms run two years for new vendors with optional extensions at MMCAP's discretion; incumbent responders' amendments align with existing expiration dates through June 30, 2028. Specific award values are not disclosed, but vendors should anticipate paying a 3 percent administrative fee on all purchases and compliance with performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials.